nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE4B—hematologic cancer	0.399	1	CbGaD
Papaverine—PDE3A—Anagrelide—hematologic cancer	0.381	1	CbGbCtD
Papaverine—PDE3B—hematopoietic system—hematologic cancer	0.00403	0.106	CbGeAlD
Papaverine—PDE3B—blood—hematologic cancer	0.00267	0.0702	CbGeAlD
Papaverine—PDE3B—bone marrow—hematologic cancer	0.00258	0.0679	CbGeAlD
Papaverine—PDE10A—lung—hematologic cancer	0.00251	0.0661	CbGeAlD
Papaverine—PDE3A—hematopoietic system—hematologic cancer	0.00246	0.0647	CbGeAlD
Papaverine—PDE10A—testis—hematologic cancer	0.00237	0.0623	CbGeAlD
Papaverine—PDE3B—lung—hematologic cancer	0.00234	0.0616	CbGeAlD
Papaverine—PDE3B—testis—hematologic cancer	0.00221	0.0581	CbGeAlD
Papaverine—PDE4B—hematopoietic system—hematologic cancer	0.00177	0.0467	CbGeAlD
Papaverine—PDE10A—lymph node—hematologic cancer	0.00172	0.0452	CbGeAlD
Papaverine—PDE3A—blood—hematologic cancer	0.00163	0.0429	CbGeAlD
Papaverine—PDE3B—lymph node—hematologic cancer	0.0016	0.0421	CbGeAlD
Papaverine—PDE3A—lung—hematologic cancer	0.00143	0.0376	CbGeAlD
Papaverine—PDE4B—gonad—hematologic cancer	0.00135	0.0355	CbGeAlD
Papaverine—PDE3A—testis—hematologic cancer	0.00135	0.0355	CbGeAlD
Papaverine—PDE4B—blood—hematologic cancer	0.00117	0.0309	CbGeAlD
Papaverine—PDE4B—bone marrow—hematologic cancer	0.00114	0.0299	CbGeAlD
Papaverine—PDE4B—lung—hematologic cancer	0.00103	0.0271	CbGeAlD
Papaverine—PDE3A—lymph node—hematologic cancer	0.000977	0.0257	CbGeAlD
Papaverine—PDE4B—testis—hematologic cancer	0.000971	0.0256	CbGeAlD
Papaverine—PDE4B—lymph node—hematologic cancer	0.000704	0.0185	CbGeAlD
Papaverine—Verapamil—ABCC3—hematologic cancer	0.000582	0.348	CrCbGaD
Papaverine—Verapamil—SLC22A1—hematologic cancer	0.000405	0.242	CrCbGaD
Papaverine—Trimethoprim—ABCB1—hematologic cancer	0.000285	0.17	CrCbGaD
Papaverine—Verapamil—ABCG2—hematologic cancer	0.000283	0.169	CrCbGaD
Papaverine—Anorexia—Carmustine—hematologic cancer	0.000166	0.00164	CcSEcCtD
Papaverine—Feeling abnormal—Bortezomib—hematologic cancer	0.000166	0.00163	CcSEcCtD
Papaverine—Nausea—Procarbazine—hematologic cancer	0.000165	0.00163	CcSEcCtD
Papaverine—Anorexia—Alitretinoin—hematologic cancer	0.000164	0.00162	CcSEcCtD
Papaverine—Feeling abnormal—Bleomycin—hematologic cancer	0.000164	0.00162	CcSEcCtD
Papaverine—Decreased appetite—Thiotepa—hematologic cancer	0.000163	0.00161	CcSEcCtD
Papaverine—Discomfort—Gemcitabine—hematologic cancer	0.000163	0.0016	CcSEcCtD
Papaverine—Anorexia—Ifosfamide—hematologic cancer	0.000163	0.0016	CcSEcCtD
Papaverine—Malaise—Cisplatin—hematologic cancer	0.000162	0.0016	CcSEcCtD
Papaverine—Nausea—Bexarotene—hematologic cancer	0.000162	0.0016	CcSEcCtD
Papaverine—Nausea—Dasatinib—hematologic cancer	0.000162	0.0016	CcSEcCtD
Papaverine—Feeling abnormal—Vinorelbine—hematologic cancer	0.000162	0.0016	CcSEcCtD
Papaverine—Nausea—Fludarabine—hematologic cancer	0.000162	0.00159	CcSEcCtD
Papaverine—Diarrhoea—Vinblastine—hematologic cancer	0.000162	0.00159	CcSEcCtD
Papaverine—Constipation—Thiotepa—hematologic cancer	0.00016	0.00158	CcSEcCtD
Papaverine—Rash—Nilotinib—hematologic cancer	0.000159	0.00157	CcSEcCtD
Papaverine—Dermatitis—Nilotinib—hematologic cancer	0.000159	0.00157	CcSEcCtD
Papaverine—Anorexia—Vincristine—hematologic cancer	0.000158	0.00156	CcSEcCtD
Papaverine—Rash—Imatinib—hematologic cancer	0.000158	0.00156	CcSEcCtD
Papaverine—Headache—Nilotinib—hematologic cancer	0.000158	0.00156	CcSEcCtD
Papaverine—Dermatitis—Imatinib—hematologic cancer	0.000158	0.00156	CcSEcCtD
Papaverine—Decreased appetite—Thalidomide—hematologic cancer	0.000158	0.00155	CcSEcCtD
Papaverine—Headache—Imatinib—hematologic cancer	0.000157	0.00155	CcSEcCtD
Papaverine—Rash—Cladribine—hematologic cancer	0.000155	0.00153	CcSEcCtD
Papaverine—Dermatitis—Cladribine—hematologic cancer	0.000155	0.00153	CcSEcCtD
Papaverine—Constipation—Thalidomide—hematologic cancer	0.000155	0.00153	CcSEcCtD
Papaverine—Feeling abnormal—Thiotepa—hematologic cancer	0.000155	0.00152	CcSEcCtD
Papaverine—Anorexia—Mitoxantrone—hematologic cancer	0.000154	0.00152	CcSEcCtD
Papaverine—Anorexia—Irinotecan—hematologic cancer	0.000154	0.00152	CcSEcCtD
Papaverine—Headache—Cladribine—hematologic cancer	0.000154	0.00152	CcSEcCtD
Papaverine—Diarrhoea—Melphalan—hematologic cancer	0.000154	0.00152	CcSEcCtD
Papaverine—Nausea—Chlorambucil—hematologic cancer	0.000153	0.00151	CcSEcCtD
Papaverine—Ill-defined disorder—Etoposide—hematologic cancer	0.000153	0.00151	CcSEcCtD
Papaverine—Discomfort—Cisplatin—hematologic cancer	0.000152	0.00149	CcSEcCtD
Papaverine—Decreased appetite—Carmustine—hematologic cancer	0.000151	0.00149	CcSEcCtD
Papaverine—Ill-defined disorder—Prednisolone—hematologic cancer	0.000151	0.00149	CcSEcCtD
Papaverine—Anorexia—Gemcitabine—hematologic cancer	0.00015	0.00148	CcSEcCtD
Papaverine—Decreased appetite—Alitretinoin—hematologic cancer	0.00015	0.00148	CcSEcCtD
Papaverine—Nausea—Nilotinib—hematologic cancer	0.00015	0.00148	CcSEcCtD
Papaverine—Diarrhoea—Lenalidomide—hematologic cancer	0.000149	0.00147	CcSEcCtD
Papaverine—Feeling abnormal—Thalidomide—hematologic cancer	0.000149	0.00147	CcSEcCtD
Papaverine—Constipation—Carmustine—hematologic cancer	0.000149	0.00147	CcSEcCtD
Papaverine—Nausea—Imatinib—hematologic cancer	0.000149	0.00147	CcSEcCtD
Papaverine—Malaise—Etoposide—hematologic cancer	0.000149	0.00147	CcSEcCtD
Papaverine—Vertigo—Etoposide—hematologic cancer	0.000148	0.00146	CcSEcCtD
Papaverine—Decreased appetite—Ifosfamide—hematologic cancer	0.000148	0.00146	CcSEcCtD
Papaverine—Headache—Vinblastine—hematologic cancer	0.000148	0.00146	CcSEcCtD
Papaverine—Constipation—Alitretinoin—hematologic cancer	0.000148	0.00146	CcSEcCtD
Papaverine—Diarrhoea—Hydroxyurea—hematologic cancer	0.000147	0.00145	CcSEcCtD
Papaverine—Malaise—Prednisolone—hematologic cancer	0.000147	0.00145	CcSEcCtD
Papaverine—Nausea—Cladribine—hematologic cancer	0.000146	0.00144	CcSEcCtD
Papaverine—Vertigo—Prednisolone—hematologic cancer	0.000146	0.00144	CcSEcCtD
Papaverine—Constipation—Ifosfamide—hematologic cancer	0.000146	0.00144	CcSEcCtD
Papaverine—Decreased appetite—Vincristine—hematologic cancer	0.000145	0.00143	CcSEcCtD
Papaverine—Feeling abnormal—Carmustine—hematologic cancer	0.000144	0.00142	CcSEcCtD
Papaverine—Feeling abnormal—Alitretinoin—hematologic cancer	0.000142	0.0014	CcSEcCtD
Papaverine—Constipation—Vincristine—hematologic cancer	0.000142	0.0014	CcSEcCtD
Papaverine—Rash—Melphalan—hematologic cancer	0.000142	0.0014	CcSEcCtD
Papaverine—Dermatitis—Melphalan—hematologic cancer	0.000142	0.0014	CcSEcCtD
Papaverine—Decreased appetite—Mitoxantrone—hematologic cancer	0.000141	0.00139	CcSEcCtD
Papaverine—Decreased appetite—Irinotecan—hematologic cancer	0.000141	0.00139	CcSEcCtD
Papaverine—Feeling abnormal—Ifosfamide—hematologic cancer	0.000141	0.00139	CcSEcCtD
Papaverine—Nausea—Vinblastine—hematologic cancer	0.00014	0.00138	CcSEcCtD
Papaverine—Anorexia—Cisplatin—hematologic cancer	0.00014	0.00138	CcSEcCtD
Papaverine—Ill-defined disorder—Triamcinolone—hematologic cancer	0.000139	0.00137	CcSEcCtD
Papaverine—Discomfort—Etoposide—hematologic cancer	0.000139	0.00137	CcSEcCtD
Papaverine—Constipation—Mitoxantrone—hematologic cancer	0.000138	0.00137	CcSEcCtD
Papaverine—Constipation—Irinotecan—hematologic cancer	0.000138	0.00137	CcSEcCtD
Papaverine—Rash—Lenalidomide—hematologic cancer	0.000138	0.00136	CcSEcCtD
Papaverine—Dermatitis—Lenalidomide—hematologic cancer	0.000138	0.00136	CcSEcCtD
Papaverine—Diarrhoea—Bortezomib—hematologic cancer	0.000138	0.00136	CcSEcCtD
Papaverine—Decreased appetite—Gemcitabine—hematologic cancer	0.000137	0.00135	CcSEcCtD
Papaverine—Discomfort—Prednisolone—hematologic cancer	0.000137	0.00135	CcSEcCtD
Papaverine—Headache—Lenalidomide—hematologic cancer	0.000137	0.00135	CcSEcCtD
Papaverine—Abdominal discomfort—Methotrexate—hematologic cancer	0.000136	0.00134	CcSEcCtD
Papaverine—Rash—Hydroxyurea—hematologic cancer	0.000136	0.00134	CcSEcCtD
Papaverine—Dermatitis—Hydroxyurea—hematologic cancer	0.000136	0.00134	CcSEcCtD
Papaverine—Malaise—Triamcinolone—hematologic cancer	0.000135	0.00133	CcSEcCtD
Papaverine—Headache—Hydroxyurea—hematologic cancer	0.000135	0.00133	CcSEcCtD
Papaverine—Constipation—Gemcitabine—hematologic cancer	0.000135	0.00133	CcSEcCtD
Papaverine—Vertigo—Triamcinolone—hematologic cancer	0.000134	0.00133	CcSEcCtD
Papaverine—Diarrhoea—Vinorelbine—hematologic cancer	0.000134	0.00132	CcSEcCtD
Papaverine—Nausea—Melphalan—hematologic cancer	0.000133	0.00132	CcSEcCtD
Papaverine—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000133	0.00132	CcSEcCtD
Papaverine—Feeling abnormal—Irinotecan—hematologic cancer	0.000133	0.00132	CcSEcCtD
Papaverine—Feeling abnormal—Gemcitabine—hematologic cancer	0.00013	0.00128	CcSEcCtD
Papaverine—Nausea—Lenalidomide—hematologic cancer	0.00013	0.00128	CcSEcCtD
Papaverine—Anorexia—Etoposide—hematologic cancer	0.000128	0.00127	CcSEcCtD
Papaverine—Diarrhoea—Thiotepa—hematologic cancer	0.000128	0.00127	CcSEcCtD
Papaverine—Nausea—Hydroxyurea—hematologic cancer	0.000128	0.00126	CcSEcCtD
Papaverine—Decreased appetite—Cisplatin—hematologic cancer	0.000128	0.00126	CcSEcCtD
Papaverine—Rash—Bortezomib—hematologic cancer	0.000127	0.00125	CcSEcCtD
Papaverine—Dermatitis—Bortezomib—hematologic cancer	0.000127	0.00125	CcSEcCtD
Papaverine—Flushing—Prednisone—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Ill-defined disorder—Betamethasone—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Ill-defined disorder—Dexamethasone—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Headache—Bortezomib—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Discomfort—Triamcinolone—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Rash—Bleomycin—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Dermatitis—Bleomycin—hematologic cancer	0.000126	0.00124	CcSEcCtD
Papaverine—Diarrhoea—Thalidomide—hematologic cancer	0.000124	0.00122	CcSEcCtD
Papaverine—Rash—Vinorelbine—hematologic cancer	0.000124	0.00122	CcSEcCtD
Papaverine—Dermatitis—Vinorelbine—hematologic cancer	0.000124	0.00122	CcSEcCtD
Papaverine—Headache—Vinorelbine—hematologic cancer	0.000123	0.00121	CcSEcCtD
Papaverine—Malaise—Betamethasone—hematologic cancer	0.000122	0.00121	CcSEcCtD
Papaverine—Malaise—Dexamethasone—hematologic cancer	0.000122	0.00121	CcSEcCtD
Papaverine—Vertigo—Betamethasone—hematologic cancer	0.000122	0.0012	CcSEcCtD
Papaverine—Vertigo—Dexamethasone—hematologic cancer	0.000122	0.0012	CcSEcCtD
Papaverine—Feeling abnormal—Cisplatin—hematologic cancer	0.000121	0.00119	CcSEcCtD
Papaverine—Nausea—Bortezomib—hematologic cancer	0.000119	0.00118	CcSEcCtD
Papaverine—Diarrhoea—Carmustine—hematologic cancer	0.000119	0.00118	CcSEcCtD
Papaverine—Nausea—Bleomycin—hematologic cancer	0.000119	0.00117	CcSEcCtD
Papaverine—Rash—Thiotepa—hematologic cancer	0.000118	0.00117	CcSEcCtD
Papaverine—Dermatitis—Thiotepa—hematologic cancer	0.000118	0.00116	CcSEcCtD
Papaverine—Diarrhoea—Alitretinoin—hematologic cancer	0.000118	0.00116	CcSEcCtD
Papaverine—Verapamil—ABCB1—hematologic cancer	0.000118	0.0704	CrCbGaD
Papaverine—Headache—Thiotepa—hematologic cancer	0.000117	0.00116	CcSEcCtD
Papaverine—Decreased appetite—Etoposide—hematologic cancer	0.000117	0.00115	CcSEcCtD
Papaverine—Diarrhoea—Ifosfamide—hematologic cancer	0.000117	0.00115	CcSEcCtD
Papaverine—Nausea—Vinorelbine—hematologic cancer	0.000117	0.00115	CcSEcCtD
Papaverine—Constipation—Etoposide—hematologic cancer	0.000115	0.00114	CcSEcCtD
Papaverine—Rash—Thalidomide—hematologic cancer	0.000114	0.00113	CcSEcCtD
Papaverine—Discomfort—Betamethasone—hematologic cancer	0.000114	0.00113	CcSEcCtD
Papaverine—Discomfort—Dexamethasone—hematologic cancer	0.000114	0.00113	CcSEcCtD
Papaverine—Dermatitis—Thalidomide—hematologic cancer	0.000114	0.00113	CcSEcCtD
Papaverine—Diarrhoea—Vincristine—hematologic cancer	0.000114	0.00112	CcSEcCtD
Papaverine—Headache—Thalidomide—hematologic cancer	0.000114	0.00112	CcSEcCtD
Papaverine—Hepatitis—Methotrexate—hematologic cancer	0.000114	0.00112	CcSEcCtD
Papaverine—Nausea—Thiotepa—hematologic cancer	0.000111	0.0011	CcSEcCtD
Papaverine—Feeling abnormal—Etoposide—hematologic cancer	0.000111	0.00109	CcSEcCtD
Papaverine—Diarrhoea—Irinotecan—hematologic cancer	0.000111	0.00109	CcSEcCtD
Papaverine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000111	0.00109	CcSEcCtD
Papaverine—Rash—Carmustine—hematologic cancer	0.00011	0.00108	CcSEcCtD
Papaverine—Ill-defined disorder—Prednisone—hematologic cancer	0.00011	0.00108	CcSEcCtD
Papaverine—Dermatitis—Carmustine—hematologic cancer	0.00011	0.00108	CcSEcCtD
Papaverine—Feeling abnormal—Prednisolone—hematologic cancer	0.000109	0.00108	CcSEcCtD
Papaverine—Headache—Carmustine—hematologic cancer	0.000109	0.00108	CcSEcCtD
Papaverine—Rash—Alitretinoin—hematologic cancer	0.000109	0.00107	CcSEcCtD
Papaverine—Dermatitis—Alitretinoin—hematologic cancer	0.000109	0.00107	CcSEcCtD
Papaverine—Headache—Alitretinoin—hematologic cancer	0.000108	0.00107	CcSEcCtD
Papaverine—Diarrhoea—Gemcitabine—hematologic cancer	0.000108	0.00106	CcSEcCtD
Papaverine—Nausea—Thalidomide—hematologic cancer	0.000108	0.00106	CcSEcCtD
Papaverine—Rash—Ifosfamide—hematologic cancer	0.000108	0.00106	CcSEcCtD
Papaverine—Dermatitis—Ifosfamide—hematologic cancer	0.000107	0.00106	CcSEcCtD
Papaverine—Malaise—Prednisone—hematologic cancer	0.000107	0.00105	CcSEcCtD
Papaverine—Vertigo—Prednisone—hematologic cancer	0.000106	0.00105	CcSEcCtD
Papaverine—Hepatitis—Epirubicin—hematologic cancer	0.000106	0.00105	CcSEcCtD
Papaverine—Anorexia—Betamethasone—hematologic cancer	0.000106	0.00104	CcSEcCtD
Papaverine—Anorexia—Dexamethasone—hematologic cancer	0.000106	0.00104	CcSEcCtD
Papaverine—Rash—Vincristine—hematologic cancer	0.000105	0.00103	CcSEcCtD
Papaverine—Dermatitis—Vincristine—hematologic cancer	0.000105	0.00103	CcSEcCtD
Papaverine—Headache—Vincristine—hematologic cancer	0.000104	0.00103	CcSEcCtD
Papaverine—Nausea—Carmustine—hematologic cancer	0.000103	0.00102	CcSEcCtD
Papaverine—Nausea—Alitretinoin—hematologic cancer	0.000102	0.00101	CcSEcCtD
Papaverine—Rash—Irinotecan—hematologic cancer	0.000102	0.00101	CcSEcCtD
Papaverine—Rash—Mitoxantrone—hematologic cancer	0.000102	0.00101	CcSEcCtD
Papaverine—Dermatitis—Mitoxantrone—hematologic cancer	0.000102	0.00101	CcSEcCtD
Papaverine—Dermatitis—Irinotecan—hematologic cancer	0.000102	0.00101	CcSEcCtD
Papaverine—Headache—Mitoxantrone—hematologic cancer	0.000101	0.001	CcSEcCtD
Papaverine—Headache—Irinotecan—hematologic cancer	0.000101	0.001	CcSEcCtD
Papaverine—Nausea—Ifosfamide—hematologic cancer	0.000101	0.000999	CcSEcCtD
Papaverine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000101	0.000993	CcSEcCtD
Papaverine—Diarrhoea—Cisplatin—hematologic cancer	0.000101	0.000992	CcSEcCtD
Papaverine—Discomfort—Prednisone—hematologic cancer	9.95e-05	0.000981	CcSEcCtD
Papaverine—Rash—Gemcitabine—hematologic cancer	9.94e-05	0.000981	CcSEcCtD
Papaverine—Dermatitis—Gemcitabine—hematologic cancer	9.94e-05	0.00098	CcSEcCtD
Papaverine—Headache—Gemcitabine—hematologic cancer	9.88e-05	0.000975	CcSEcCtD
Papaverine—Nausea—Vincristine—hematologic cancer	9.88e-05	0.000974	CcSEcCtD
Papaverine—Flushing—Epirubicin—hematologic cancer	9.86e-05	0.000973	CcSEcCtD
Papaverine—Hepatitis—Doxorubicin—hematologic cancer	9.83e-05	0.00097	CcSEcCtD
Papaverine—Decreased appetite—Betamethasone—hematologic cancer	9.64e-05	0.00095	CcSEcCtD
Papaverine—Decreased appetite—Dexamethasone—hematologic cancer	9.64e-05	0.00095	CcSEcCtD
Papaverine—Nausea—Mitoxantrone—hematologic cancer	9.62e-05	0.000949	CcSEcCtD
Papaverine—Nausea—Irinotecan—hematologic cancer	9.62e-05	0.000949	CcSEcCtD
Papaverine—Nausea—Gemcitabine—hematologic cancer	9.37e-05	0.000924	CcSEcCtD
Papaverine—Rash—Cisplatin—hematologic cancer	9.27e-05	0.000914	CcSEcCtD
Papaverine—Dermatitis—Cisplatin—hematologic cancer	9.26e-05	0.000913	CcSEcCtD
Papaverine—Diarrhoea—Etoposide—hematologic cancer	9.21e-05	0.000909	CcSEcCtD
Papaverine—Anorexia—Prednisone—hematologic cancer	9.2e-05	0.000908	CcSEcCtD
Papaverine—Ill-defined disorder—Methotrexate—hematologic cancer	9.17e-05	0.000905	CcSEcCtD
Papaverine—Feeling abnormal—Dexamethasone—hematologic cancer	9.13e-05	0.000901	CcSEcCtD
Papaverine—Feeling abnormal—Betamethasone—hematologic cancer	9.13e-05	0.000901	CcSEcCtD
Papaverine—Flushing—Doxorubicin—hematologic cancer	9.12e-05	0.0009	CcSEcCtD
Papaverine—Malaise—Methotrexate—hematologic cancer	8.91e-05	0.000879	CcSEcCtD
Papaverine—Vertigo—Methotrexate—hematologic cancer	8.88e-05	0.000876	CcSEcCtD
Papaverine—Nausea—Cisplatin—hematologic cancer	8.73e-05	0.000861	CcSEcCtD
Papaverine—Ill-defined disorder—Epirubicin—hematologic cancer	8.58e-05	0.000847	CcSEcCtD
Papaverine—Rash—Etoposide—hematologic cancer	8.49e-05	0.000838	CcSEcCtD
Papaverine—Dermatitis—Etoposide—hematologic cancer	8.48e-05	0.000837	CcSEcCtD
Papaverine—Headache—Etoposide—hematologic cancer	8.44e-05	0.000832	CcSEcCtD
Papaverine—Decreased appetite—Prednisone—hematologic cancer	8.39e-05	0.000828	CcSEcCtD
Papaverine—Rash—Prednisolone—hematologic cancer	8.38e-05	0.000826	CcSEcCtD
Papaverine—Dermatitis—Prednisolone—hematologic cancer	8.37e-05	0.000825	CcSEcCtD
Papaverine—Malaise—Epirubicin—hematologic cancer	8.34e-05	0.000823	CcSEcCtD
Papaverine—Headache—Prednisolone—hematologic cancer	8.32e-05	0.000821	CcSEcCtD
Papaverine—Discomfort—Methotrexate—hematologic cancer	8.31e-05	0.00082	CcSEcCtD
Papaverine—Vertigo—Epirubicin—hematologic cancer	8.31e-05	0.00082	CcSEcCtD
Papaverine—Constipation—Prednisone—hematologic cancer	8.25e-05	0.000814	CcSEcCtD
Papaverine—Nausea—Etoposide—hematologic cancer	8e-05	0.000789	CcSEcCtD
Papaverine—Feeling abnormal—Prednisone—hematologic cancer	7.95e-05	0.000785	CcSEcCtD
Papaverine—Ill-defined disorder—Doxorubicin—hematologic cancer	7.94e-05	0.000783	CcSEcCtD
Papaverine—Nausea—Prednisolone—hematologic cancer	7.89e-05	0.000778	CcSEcCtD
Papaverine—Discomfort—Epirubicin—hematologic cancer	7.78e-05	0.000767	CcSEcCtD
Papaverine—Malaise—Doxorubicin—hematologic cancer	7.72e-05	0.000761	CcSEcCtD
Papaverine—Rash—Triamcinolone—hematologic cancer	7.7e-05	0.00076	CcSEcCtD
Papaverine—Dermatitis—Triamcinolone—hematologic cancer	7.69e-05	0.000759	CcSEcCtD
Papaverine—Vertigo—Doxorubicin—hematologic cancer	7.69e-05	0.000758	CcSEcCtD
Papaverine—Anorexia—Methotrexate—hematologic cancer	7.69e-05	0.000758	CcSEcCtD
Papaverine—Headache—Triamcinolone—hematologic cancer	7.65e-05	0.000755	CcSEcCtD
Papaverine—Diarrhoea—Dexamethasone—hematologic cancer	7.58e-05	0.000748	CcSEcCtD
Papaverine—Diarrhoea—Betamethasone—hematologic cancer	7.58e-05	0.000748	CcSEcCtD
Papaverine—Nausea—Triamcinolone—hematologic cancer	7.26e-05	0.000716	CcSEcCtD
Papaverine—Discomfort—Doxorubicin—hematologic cancer	7.2e-05	0.00071	CcSEcCtD
Papaverine—Anorexia—Epirubicin—hematologic cancer	7.2e-05	0.00071	CcSEcCtD
Papaverine—Decreased appetite—Methotrexate—hematologic cancer	7.01e-05	0.000692	CcSEcCtD
Papaverine—Rash—Betamethasone—hematologic cancer	6.99e-05	0.000689	CcSEcCtD
Papaverine—Rash—Dexamethasone—hematologic cancer	6.99e-05	0.000689	CcSEcCtD
Papaverine—Dermatitis—Betamethasone—hematologic cancer	6.98e-05	0.000689	CcSEcCtD
Papaverine—Dermatitis—Dexamethasone—hematologic cancer	6.98e-05	0.000689	CcSEcCtD
Papaverine—Headache—Dexamethasone—hematologic cancer	6.94e-05	0.000685	CcSEcCtD
Papaverine—Headache—Betamethasone—hematologic cancer	6.94e-05	0.000685	CcSEcCtD
Papaverine—Anorexia—Doxorubicin—hematologic cancer	6.66e-05	0.000657	CcSEcCtD
Papaverine—Feeling abnormal—Methotrexate—hematologic cancer	6.65e-05	0.000656	CcSEcCtD
Papaverine—Diarrhoea—Prednisone—hematologic cancer	6.6e-05	0.000651	CcSEcCtD
Papaverine—Nausea—Betamethasone—hematologic cancer	6.58e-05	0.000649	CcSEcCtD
Papaverine—Nausea—Dexamethasone—hematologic cancer	6.58e-05	0.000649	CcSEcCtD
Papaverine—Decreased appetite—Epirubicin—hematologic cancer	6.56e-05	0.000647	CcSEcCtD
Papaverine—Constipation—Epirubicin—hematologic cancer	6.46e-05	0.000637	CcSEcCtD
Papaverine—Feeling abnormal—Epirubicin—hematologic cancer	6.22e-05	0.000614	CcSEcCtD
Papaverine—Rash—Prednisone—hematologic cancer	6.09e-05	0.0006	CcSEcCtD
Papaverine—Dermatitis—Prednisone—hematologic cancer	6.08e-05	0.0006	CcSEcCtD
Papaverine—Decreased appetite—Doxorubicin—hematologic cancer	6.07e-05	0.000599	CcSEcCtD
Papaverine—Headache—Prednisone—hematologic cancer	6.05e-05	0.000596	CcSEcCtD
Papaverine—Constipation—Doxorubicin—hematologic cancer	5.97e-05	0.000589	CcSEcCtD
Papaverine—Feeling abnormal—Doxorubicin—hematologic cancer	5.76e-05	0.000568	CcSEcCtD
Papaverine—Nausea—Prednisone—hematologic cancer	5.73e-05	0.000566	CcSEcCtD
Papaverine—Diarrhoea—Methotrexate—hematologic cancer	5.52e-05	0.000544	CcSEcCtD
Papaverine—Diarrhoea—Epirubicin—hematologic cancer	5.17e-05	0.000509	CcSEcCtD
Papaverine—Rash—Methotrexate—hematologic cancer	5.09e-05	0.000502	CcSEcCtD
Papaverine—Dermatitis—Methotrexate—hematologic cancer	5.08e-05	0.000501	CcSEcCtD
Papaverine—Headache—Methotrexate—hematologic cancer	5.05e-05	0.000498	CcSEcCtD
Papaverine—Nausea—Methotrexate—hematologic cancer	4.79e-05	0.000473	CcSEcCtD
Papaverine—Diarrhoea—Doxorubicin—hematologic cancer	4.78e-05	0.000471	CcSEcCtD
Papaverine—Rash—Epirubicin—hematologic cancer	4.76e-05	0.000469	CcSEcCtD
Papaverine—Dermatitis—Epirubicin—hematologic cancer	4.76e-05	0.000469	CcSEcCtD
Papaverine—Headache—Epirubicin—hematologic cancer	4.73e-05	0.000466	CcSEcCtD
Papaverine—Nausea—Epirubicin—hematologic cancer	4.48e-05	0.000442	CcSEcCtD
Papaverine—Rash—Doxorubicin—hematologic cancer	4.4e-05	0.000434	CcSEcCtD
Papaverine—Dermatitis—Doxorubicin—hematologic cancer	4.4e-05	0.000434	CcSEcCtD
Papaverine—Headache—Doxorubicin—hematologic cancer	4.38e-05	0.000432	CcSEcCtD
Papaverine—Nausea—Doxorubicin—hematologic cancer	4.15e-05	0.000409	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—PIK3R1—hematologic cancer	1.44e-05	0.000184	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3R1—hematologic cancer	1.44e-05	0.000184	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—HRAS—hematologic cancer	1.43e-05	0.000183	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KITLG—hematologic cancer	1.43e-05	0.000182	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—PIK3CA—hematologic cancer	1.41e-05	0.00018	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CD86—hematologic cancer	1.41e-05	0.000179	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—JAK2—hematologic cancer	1.4e-05	0.000179	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—JAK2—hematologic cancer	1.4e-05	0.000178	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STAT5A—hematologic cancer	1.39e-05	0.000178	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CB—hematologic cancer	1.39e-05	0.000177	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HES1—hematologic cancer	1.39e-05	0.000177	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN2B—hematologic cancer	1.38e-05	0.000176	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NCOR1—hematologic cancer	1.38e-05	0.000176	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PIK3CA—hematologic cancer	1.37e-05	0.000175	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3R1—hematologic cancer	1.37e-05	0.000175	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MDM2—hematologic cancer	1.37e-05	0.000175	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—hematologic cancer	1.36e-05	0.000174	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGF1—hematologic cancer	1.36e-05	0.000174	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CSF2—hematologic cancer	1.36e-05	0.000174	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2RA—hematologic cancer	1.35e-05	0.000172	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FOXO1—hematologic cancer	1.34e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—IL2—hematologic cancer	1.34e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PDGFRB—hematologic cancer	1.34e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL2—hematologic cancer	1.34e-05	0.000171	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CD86—hematologic cancer	1.34e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TERT—hematologic cancer	1.33e-05	0.00017	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MTOR—hematologic cancer	1.33e-05	0.00017	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CB—hematologic cancer	1.33e-05	0.00017	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—JAK2—hematologic cancer	1.33e-05	0.00017	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CB—hematologic cancer	1.33e-05	0.000169	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PDGFRA—hematologic cancer	1.32e-05	0.000168	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HES1—hematologic cancer	1.32e-05	0.000168	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—JAK1—hematologic cancer	1.32e-05	0.000168	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PRKCG—hematologic cancer	1.32e-05	0.000168	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NCOR1—hematologic cancer	1.31e-05	0.000167	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—HRAS—hematologic cancer	1.3e-05	0.000167	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PDGFB—hematologic cancer	1.3e-05	0.000166	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGF1—hematologic cancer	1.3e-05	0.000165	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CSF2—hematologic cancer	1.3e-05	0.000165	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FOXO1—hematologic cancer	1.28e-05	0.000163	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—IL2—hematologic cancer	1.28e-05	0.000163	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PDGFRB—hematologic cancer	1.28e-05	0.000163	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TSC2—hematologic cancer	1.27e-05	0.000162	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—HRAS—hematologic cancer	1.27e-05	0.000162	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—hematologic cancer	1.26e-05	0.000161	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CB—hematologic cancer	1.26e-05	0.000161	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PDGFRA—hematologic cancer	1.26e-05	0.00016	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—JAK1—hematologic cancer	1.25e-05	0.00016	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PRKCG—hematologic cancer	1.25e-05	0.00016	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1B—hematologic cancer	1.25e-05	0.000159	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—hematologic cancer	1.23e-05	0.000158	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2RA—hematologic cancer	1.23e-05	0.000157	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGFR3—hematologic cancer	1.22e-05	0.000156	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CASP3—hematologic cancer	1.22e-05	0.000156	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL2—hematologic cancer	1.22e-05	0.000156	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL2—hematologic cancer	1.22e-05	0.000156	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—hematologic cancer	1.22e-05	0.000155	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TERT—hematologic cancer	1.21e-05	0.000155	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK14—hematologic cancer	1.21e-05	0.000155	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCND1—hematologic cancer	1.19e-05	0.000152	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ESR1—hematologic cancer	1.19e-05	0.000152	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—JUN—hematologic cancer	1.19e-05	0.000152	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PDGFB—hematologic cancer	1.19e-05	0.000151	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FN1—hematologic cancer	1.17e-05	0.00015	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2RA—hematologic cancer	1.17e-05	0.000149	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—BAD—hematologic cancer	1.16e-05	0.000148	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NFKBIA—hematologic cancer	1.16e-05	0.000148	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL2—hematologic cancer	1.16e-05	0.000148	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TSC2—hematologic cancer	1.16e-05	0.000148	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TERT—hematologic cancer	1.16e-05	0.000147	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1A—hematologic cancer	1.15e-05	0.000147	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—hematologic cancer	1.15e-05	0.000147	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTEN—hematologic cancer	1.15e-05	0.000147	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NOTCH1—hematologic cancer	1.15e-05	0.000147	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PDGFB—hematologic cancer	1.13e-05	0.000144	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CD80—hematologic cancer	1.13e-05	0.000144	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAPK8—hematologic cancer	1.12e-05	0.000144	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CG—hematologic cancer	1.12e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KIT—hematologic cancer	1.12e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—NRAS—hematologic cancer	1.12e-05	0.000143	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—hematologic cancer	1.12e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGFR3—hematologic cancer	1.11e-05	0.000142	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTPN11—hematologic cancer	1.1e-05	0.000141	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK14—hematologic cancer	1.1e-05	0.000141	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TSC2—hematologic cancer	1.1e-05	0.000141	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EP300—hematologic cancer	1.1e-05	0.00014	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ESR1—hematologic cancer	1.08e-05	0.000138	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—MAPK3—hematologic cancer	1.08e-05	0.000137	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CREB1—hematologic cancer	1.07e-05	0.000137	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FN1—hematologic cancer	1.07e-05	0.000136	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SRC—hematologic cancer	1.07e-05	0.000136	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGFR3—hematologic cancer	1.06e-05	0.000135	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—BAD—hematologic cancer	1.06e-05	0.000135	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NFKBIA—hematologic cancer	1.06e-05	0.000135	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—BRAF—hematologic cancer	1.06e-05	0.000135	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK14—hematologic cancer	1.05e-05	0.000134	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCL2—hematologic cancer	1.05e-05	0.000134	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NOTCH1—hematologic cancer	1.05e-05	0.000134	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6R—hematologic cancer	1.04e-05	0.000133	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CREBBP—hematologic cancer	1.04e-05	0.000133	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VEGFA—hematologic cancer	1.04e-05	0.000133	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ESR1—hematologic cancer	1.03e-05	0.000131	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—STAT3—hematologic cancer	1.03e-05	0.000131	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NRAS—hematologic cancer	1.03e-05	0.000131	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CD80—hematologic cancer	1.03e-05	0.000131	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CG—hematologic cancer	1.02e-05	0.000131	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KIT—hematologic cancer	1.02e-05	0.000131	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—NRAS—hematologic cancer	1.02e-05	0.000131	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FN1—hematologic cancer	1.02e-05	0.00013	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTPN11—hematologic cancer	1.01e-05	0.000128	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NFKBIA—hematologic cancer	1e-05	0.000128	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—BAD—hematologic cancer	1e-05	0.000128	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NOTCH1—hematologic cancer	9.95e-06	0.000127	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAP2K1—hematologic cancer	9.94e-06	0.000127	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CD—hematologic cancer	9.88e-06	0.000126	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAPK3—hematologic cancer	9.82e-06	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MAPK3—hematologic cancer	9.8e-06	0.000125	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3CA—hematologic cancer	9.78e-06	0.000125	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CD80—hematologic cancer	9.75e-06	0.000124	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CREB1—hematologic cancer	9.74e-06	0.000124	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KIT—hematologic cancer	9.73e-06	0.000124	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CG—hematologic cancer	9.73e-06	0.000124	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—NRAS—hematologic cancer	9.73e-06	0.000124	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KRAS—hematologic cancer	9.67e-06	0.000123	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—BRAF—hematologic cancer	9.62e-06	0.000123	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTPN11—hematologic cancer	9.56e-06	0.000122	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MYC—hematologic cancer	9.55e-06	0.000122	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TGFB1—hematologic cancer	9.53e-06	0.000122	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCL2—hematologic cancer	9.53e-06	0.000122	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6R—hematologic cancer	9.5e-06	0.000121	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CREBBP—hematologic cancer	9.49e-06	0.000121	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGF2—hematologic cancer	9.46e-06	0.000121	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3R1—hematologic cancer	9.33e-06	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MAPK3—hematologic cancer	9.32e-06	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CREB1—hematologic cancer	9.26e-06	0.000118	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—BRAF—hematologic cancer	9.15e-06	0.000117	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCL2—hematologic cancer	9.06e-06	0.000116	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—JAK2—hematologic cancer	9.06e-06	0.000116	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAP2K1—hematologic cancer	9.05e-06	0.000116	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6R—hematologic cancer	9.04e-06	0.000115	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CREBBP—hematologic cancer	9.02e-06	0.000115	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CD—hematologic cancer	8.99e-06	0.000115	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CA—hematologic cancer	8.91e-06	0.000114	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CA—hematologic cancer	8.88e-06	0.000113	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MDM2—hematologic cancer	8.85e-06	0.000113	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KRAS—hematologic cancer	8.83e-06	0.000113	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KRAS—hematologic cancer	8.81e-06	0.000112	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAP2K1—hematologic cancer	8.61e-06	0.00011	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGF2—hematologic cancer	8.61e-06	0.00011	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CB—hematologic cancer	8.61e-06	0.00011	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MTOR—hematologic cancer	8.61e-06	0.00011	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CD—hematologic cancer	8.56e-06	0.000109	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3R1—hematologic cancer	8.49e-06	0.000108	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CA—hematologic cancer	8.47e-06	0.000108	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KRAS—hematologic cancer	8.38e-06	0.000107	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—JAK2—hematologic cancer	8.26e-06	0.000105	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—HRAS—hematologic cancer	8.22e-06	0.000105	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGF2—hematologic cancer	8.19e-06	0.000105	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CA—hematologic cancer	8.11e-06	0.000104	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CA—hematologic cancer	8.09e-06	0.000103	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3R1—hematologic cancer	8.08e-06	0.000103	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1B—hematologic cancer	8.08e-06	0.000103	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MDM2—hematologic cancer	8.06e-06	0.000103	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—hematologic cancer	7.99e-06	0.000102	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CASP3—hematologic cancer	7.92e-06	0.000101	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2—hematologic cancer	7.91e-06	0.000101	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—hematologic cancer	7.87e-06	0.0001	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—JAK2—hematologic cancer	7.85e-06	0.0001	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—hematologic cancer	7.85e-06	0.0001	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CB—hematologic cancer	7.84e-06	0.0001	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MTOR—hematologic cancer	7.84e-06	0.0001	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCND1—hematologic cancer	7.71e-06	9.84e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CA—hematologic cancer	7.7e-06	9.82e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—JUN—hematologic cancer	7.69e-06	9.82e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MDM2—hematologic cancer	7.66e-06	9.78e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HRAS—hematologic cancer	7.5e-06	9.58e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—HRAS—hematologic cancer	7.49e-06	9.56e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CB—hematologic cancer	7.46e-06	9.52e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MTOR—hematologic cancer	7.46e-06	9.52e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1A—hematologic cancer	7.46e-06	9.52e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTEN—hematologic cancer	7.44e-06	9.5e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1B—hematologic cancer	7.36e-06	9.39e-05	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—hematologic cancer	7.28e-06	9.29e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK8—hematologic cancer	7.28e-06	9.29e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—hematologic cancer	7.26e-06	9.26e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CASP3—hematologic cancer	7.21e-06	9.21e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2—hematologic cancer	7.2e-06	9.19e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—hematologic cancer	7.18e-06	9.17e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—hematologic cancer	7.16e-06	9.15e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—HRAS—hematologic cancer	7.12e-06	9.09e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EP300—hematologic cancer	7.09e-06	9.06e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCND1—hematologic cancer	7.02e-06	8.96e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—JUN—hematologic cancer	7e-06	8.94e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1B—hematologic cancer	7e-06	8.93e-05	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—hematologic cancer	6.92e-06	8.84e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SRC—hematologic cancer	6.9e-06	8.81e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CASP3—hematologic cancer	6.86e-06	8.76e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2—hematologic cancer	6.85e-06	8.74e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—hematologic cancer	6.81e-06	8.7e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1A—hematologic cancer	6.79e-06	8.67e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTEN—hematologic cancer	6.77e-06	8.65e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VEGFA—hematologic cancer	6.72e-06	8.58e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCND1—hematologic cancer	6.68e-06	8.52e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—JUN—hematologic cancer	6.66e-06	8.51e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—STAT3—hematologic cancer	6.65e-06	8.49e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NRAS—hematologic cancer	6.64e-06	8.47e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK8—hematologic cancer	6.63e-06	8.46e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—hematologic cancer	6.62e-06	8.46e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—hematologic cancer	6.61e-06	8.44e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EP300—hematologic cancer	6.46e-06	8.25e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1A—hematologic cancer	6.46e-06	8.25e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTEN—hematologic cancer	6.44e-06	8.23e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK3—hematologic cancer	6.36e-06	8.11e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK8—hematologic cancer	6.3e-06	8.05e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—hematologic cancer	6.29e-06	8.03e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SRC—hematologic cancer	6.28e-06	8.02e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MYC—hematologic cancer	6.18e-06	7.89e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TGFB1—hematologic cancer	6.17e-06	7.87e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EP300—hematologic cancer	6.15e-06	7.85e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VEGFA—hematologic cancer	6.12e-06	7.81e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STAT3—hematologic cancer	6.06e-06	7.74e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NRAS—hematologic cancer	6.04e-06	7.72e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SRC—hematologic cancer	5.98e-06	7.63e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VEGFA—hematologic cancer	5.82e-06	7.43e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK3—hematologic cancer	5.79e-06	7.39e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STAT3—hematologic cancer	5.76e-06	7.36e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NRAS—hematologic cancer	5.75e-06	7.34e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KRAS—hematologic cancer	5.71e-06	7.29e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MYC—hematologic cancer	5.63e-06	7.19e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFB1—hematologic cancer	5.62e-06	7.17e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK3—hematologic cancer	5.51e-06	7.03e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MYC—hematologic cancer	5.36e-06	6.84e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFB1—hematologic cancer	5.34e-06	6.82e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CA—hematologic cancer	5.25e-06	6.7e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KRAS—hematologic cancer	5.2e-06	6.64e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—hematologic cancer	5.08e-06	6.48e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KRAS—hematologic cancer	4.95e-06	6.32e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HRAS—hematologic cancer	4.86e-06	6.2e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	4.78e-06	6.1e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—hematologic cancer	4.65e-06	5.93e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—hematologic cancer	4.62e-06	5.9e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CA—hematologic cancer	4.55e-06	5.8e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HRAS—hematologic cancer	4.42e-06	5.65e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—hematologic cancer	4.4e-06	5.61e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—hematologic cancer	4.29e-06	5.47e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—hematologic cancer	4.23e-06	5.4e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HRAS—hematologic cancer	4.21e-06	5.37e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—hematologic cancer	4.03e-06	5.14e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—hematologic cancer	3.9e-06	4.98e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—hematologic cancer	3.71e-06	4.74e-05	CbGpPWpGaD
